Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer

NCT06634173 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT06634173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06634173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer
Lead sponsor
The Netherlands Cancer Institute
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2024
Completion date
December 1, 2025
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, prostate cancer metastatic